PLAN B ONE-STEP OTC
Generic Name and Formulations:
Levonorgestrel 1.5mg; tabs.
Indications for PLAN B ONE-STEP:
Prevention of pregnancy after known or suspected contraceptive failure or unprotected intercourse. Not for use as regular contraceptive.
Rule out pregnancy first. Take one single-dose as soon as possible but no later than 72hrs after unprotected intercourse. If vomiting occurs within 2hrs, may consider repeating dose.
See full labeling. Known or suspected pregnancy.
See full labeling. Ectopic pregnancy. Does not protect against HIV or other STDs.
May be antagonized by CYP3A4 inducers (eg, efavirenz, rifampin, barbiturates, carbamazepine, phenytoin, St. John's wort).
Heavier menstrual bleeding, nausea, vomiting, abdominal pain, fatigue, headache, dizziness, breast tenderness, delay of menses (>7days).
Endocrinology Advisor Articles
- Testosterone Use Remains High Among Men With Coronary Artery Disease
- Primary Characteristics of PCOS Predictive of Obstetric Complications
- Comparing Osteoporosis Screening, Treatment Strategies in Postmenopausal Women
- Maternal Thyroid Function in Pregnancy Linked to Childhood Risk for Disease
- Cerebral Small Vessel Disease More Common in Individuals With T1D vs General Population
- ADA's 2019 Standards of Medical Care in Diabetes Focus on Patient-Centered Care
- Sleep Habits Affect Insulin Sensitivity in Adolescents With Overweight, Obesity
- Levothyroxine Associated With Increased Mortality in Patients With Heart Failure
- Head-to-Head Comparison of Professional vs Personal CGM Systems in T1D
- Dual vs Triple Therapy for Metformin Treatment Intensification in Type 2 Diabetes
- Insulin Analogs vs Regular Human Insulin for Type 2 Diabetes
- Diabetic Ketoacidosis May Affect Brain Development in Children With T1D
- Higher Rates of Comorbidities Among Holocaust Survivors
- Population Health Data May Help Identify Patients at Risk for CVD
- Newborn Genomic Sequencing Can Identify Disease Risk